Stanford Dropout Says Blood Startup Won't Be Another Theranos
- Athelas highlights data amid echoes of Theranos’s origin story
- FDA reviewing efficacy of tests against standard blood draws
This article is for subscribers only.
A Stanford University dropout wants to change blood testing with a machine that promises precise results from a fingerprick.
This is not the story of turtleneck-wearing Elizabeth Holmes’s Theranos Inc. -- which soared to fame and then just as spectacularly crashed to Earth two years ago. With this new startup, some investors believe, things will be different.